Eiger BioPharmaceuticals, Inc.·4

Mar 25, 9:51 PM ET

Glenn Jeffrey S 4

4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 25, 2019

Insider Transaction Report

Form 4
Period: 2019-03-21
Transactions
  • Award

    Stock Option ( Right to Buy)

    2019-03-21+10,00010,000 total
    Exercise: $14.31Exp: 2029-03-20Common Shares (10,000 underlying)
Footnotes (1)
  • [F1]The option vests in equal monthly installments over 12 months measured from March 21, 2019 subject to Reporting Person's continuous service status as of each such date.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_844320

    POA DOCUMENT